Appeal No. 2006-3260 Page 2
Application No. 10/384,044
33. The composition according to claim 19, wherein said composition also
includes a solubility enhancer.
The references relied upon by the Examiner are:
Grebow et al. (Grebow) GB 2 293 103 Mar. 20, 1996
(Remington’s) Remington’s Pharmaceutical Sciences, pp. 113-1134, 1613, 1629-
1632 and 1694-1712 (Alfonso R. Gennaro, et al. eds., 18th ed., Philadelphia
College of Pharmacy and Science, 1990)
GROUND OF REJECTION
Claims 1-12, 14, 16-19, 21-29 and 31-36 stand rejected under 35 U.S.C.
§ 103 as being unpatentable over the combination of Grebow and Remington’s.
We affirm.
CLAIM GROUPING
We note that Appellants provide separate arguments for claims 17, 18, 33
and 34 in accordance with 37 CFR § 41.37(c)(1)(vii). See Brief, page 10.
Accordingly, we understand Appellants’ Brief to set forth the following two groups
of claims: I. Claims 1-12, 14, 16, 19, 21-29, 31, 32, 35 and 56; and II. Claims 17,
18, 33 and 34.2 Accordingly, we limit our discussion to representative claims 19
and 33. Claims 1-12, 14, 16, 21-29, 31, 32, 35 and 56 will stand or fall together
with claim 19. Claims 17, 18 and 34 will stand or fall together with claim 33.
2 We recognize Appellants’ statement at page 7 of the Brief, which merely points out what claims
recite. We do not find this statement to be an argument for separate patentability of these claims.
37 C.F.R. § 41.37(c)(1)(vii).
Page: Previous 1 2 3 4 5 6 7 8 9 Next
Last modified: September 9, 2013